GNH USA

Europe — EMA

Menopur

GNH USA supplies Menopur (Menotropin), a gonadotropin (FSH/LH) preparation for anovulatory infertility and reproductive technology.

Menotrophin

Request sourcing

1
Pack/s

What is Menotrophin?

Menotropin, the active ingredient in Menopur, is a gonadotropin (FSH/LH) preparation presented as an injectable solution for intramuscular and subcutaneous use. It treats infertility caused by anovulation and is used to stimulate ovarian follicular development in assisted reproductive technology cycles.

GNH USA supplies Menopur as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Menotrophin used for?

Menopur is used in reproductive medicine to support ovarian stimulation in infertility treatment. - Anovulatory infertility: promotes follicular growth to enable ovulation. - Assisted reproductive technology (IVF/ICSI): provides controlled ovarian stimulation for egg retrieval. - Polycystic ovary syndrome: enhances follicular response to achieve ovulation.

What are the side effects of Menotrophin?

Menopur may cause a range of adverse reactions, which are generally related to its hormonal activity and injection site.

Common Side Effects: - Injection site reactions: redness, swelling, or pain at the injection site. - Mild ovarian hyperstimulation syndrome: abdominal discomfort, bloating, nausea. - Headache: mild to moderate intensity. - Mood changes: irritability or emotional lability.

Serious or Rare Side Effects: - Severe ovarian hyperstimulation syndrome: rapid weight gain, shortness of breath, electrolyte imbalance, may require hospitalization. - Thromboembolic events: deep vein thrombosis or pulmonary embolism. - Allergic reactions: rash, urticaria, anaphylaxis.

What precautions apply to Menotrophin?

When using Menopur, clinicians should observe several safety measures. - Patient selection: assess baseline ovarian reserve and risk factors for OHSS before initiating therapy. - Monitoring: perform regular ultrasound and estradiol measurements to adjust dose. - Pregnancy status: avoid use in confirmed pregnancy; treatment is intended for ovulation induction. - Concurrent hormonal therapy: coordinate with other gonadotropins or estrogen preparations to prevent excessive stimulation. - Contraindications: do not use in patients with ovarian cysts, uncontrolled thyroid disease, or active malignancy. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Menotrophin interact with?

Menopur can interact with several medications that affect ovarian response or clotting.

Major Interactions (Avoid): - GnRH agonists/antagonists: concurrent high‑dose use may exacerbate ovarian hyperstimulation. - Estrogen‑containing contraceptives: may blunt response and increase risk of OHSS. - Thyroid hormone therapy: uncontrolled thyroid disease can alter response; adjust accordingly.

Moderate Interactions (Monitor Closely): - Anticoagulants: OHSS can increase risk of thrombosis; monitor coagulation parameters. - Corticosteroids: may affect follicular development; monitor response. - Diuretics: may mask fluid shifts in OHSS; observe closely.

Frequently asked questions

What is Menopur used for?+
Menopur is a gonadotropin preparation containing menotropin (FSH and LH) used in fertility treatment to stimulate ovarian follicular development in women with anovulatory infertility or undergoing assisted reproductive technology such as IVF. It helps achieve multiple mature eggs for retrieval.
How does menotropin work?+
Menotropin provides both FSH and LH activity. FSH binds to receptors on granulosa cells, promoting follicle growth and estradiol synthesis, while LH acts on theca cells and later on mature granulosa cells to support androgen production and final oocyte maturation. The combined effect mimics the natural pituitary surge, leading to development of multiple follicles.
What is the usual dose of Menopur?+
The prescribed dose of Menopur is individualized by the treating physician based on the patient’s ovarian reserve, response to prior stimulation, and the specific assisted reproduction protocol. The prescriber determines the number of international units (IU) per injection and the duration of treatment, adjusting as needed during monitoring.
Is Menopur safe during pregnancy or breastfeeding?+
Menopur is intended for use before conception to induce ovulation; it is not administered during an established pregnancy. Its safety in pregnancy has not been established, and it is generally contraindicated. Limited data are available for breastfeeding, and the product should be avoided unless the benefits outweigh potential risks as assessed by a healthcare professional.
How do I order Menopur from GNH USA?+
To request Menopur, visit the product page on gnh-usa.com, enter the desired quantity, and submit the inquiry form. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifying trade or institutional credentials before providing pricing, availability, shipping details (including cold‑chain handling if required), and necessary import documentation.
How does Menopur compare with other gonadotropin products?+
Menopur contains both FSH and LH activity in a single preparation, whereas some alternatives provide only FSH (e.g., recombinant FSH) and require separate LH supplementation. The combined formulation can simplify dosing and may be advantageous in patients who benefit from LH activity, but individual response and cost considerations determine the preferred product for each treatment cycle.
How should Menopur be stored and handled?+
Menopur must be stored refrigerated at 2‑8 °C, protected from light, and should never be frozen or shaken. Keep the vials in the original packaging until use, and discard any solution that appears discolored or contains particles. Follow local pharmacy or clinic protocols for cold‑chain management during transport.
How is Menopur administered?+
Menopur is supplied as a sterile injectable solution for intramuscular or subcutaneous injection. The medication is reconstituted with the appropriate diluent according to the package insert, and the prescribed dose is drawn into a sterile syringe. Injections are typically given once daily, but the exact schedule is determined by the treating physician.
What are the most serious risks associated with Menopur?+
The most serious risk is ovarian hyperstimulation syndrome (OHSS), which can range from mild abdominal discomfort to severe fluid accumulation, electrolyte imbalance, and thromboembolic complications requiring hospitalization. Rarely, allergic reactions including anaphylaxis may occur. Patients should be monitored closely for signs of OHSS and any severe adverse events.
Who should not use Menopur?+
Menopur is contraindicated in women with known hypersensitivity to menotropin or any excipients, those with ovarian cysts, uncontrolled thyroid disease, active malignancy, or established pregnancy. It should also be avoided in patients with severe ovarian hyperstimulation syndrome risk factors unless the benefits clearly outweigh the risks, as assessed by a qualified clinician.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Menotrophin
Route
Intramuscular Use , Subcutaneous Use
Manufacturer
Ferring Pharmaceuticals Ltd.
Origin
EU

Related products